Allergan AGN
-
New Morningstar Analyst Report - Hospira, Inc.
… are effectively steering Hospira in the right direction. Ball assumed the CEO role at Hospira after a long stint at Allergan AGN , most recently as the company's president. Since the CEO transition, Hospira has changed or created a number of …
-
UK cost body backs Botox for some migraine patients
LONDON, May 11 (Reuters) - Britain's healthcare cost-effectiveness body NICE has changed its mind on Allergan 's anti-wrinkle injection Botox and decided it is worth paying for on the state-funded health service for some patients suffering migraines.
-
L'Oreal loses EU trademark battle to Allergan's Botox
… lost its bid to keep a cosmetics trademark on Thursday, with Europe's highest court ruling it could not use the Botocyl mark as it would be riding on the coattails of U.S. healthcare group Allergan 's well-known Botox brand name.
-
Cramer's Mad Money - 7 Growth Stocks To Buy On Down Days (5/9/12)
… Program, Wednesday May 9. Apple ( AAPL ), Starbucks ( SBUX ), Chipotle Mexican Grill ( CMG ), Ross Stores ( ROST ), Allergan ( AGN ), Celgene ( CELG ), Lululemon ( LULU ). Other stocks mentioned: Fossil ( FOSL ), Bed Bath and Beyond ( BBBY …
-
Excluding Large Research Expense, Medicis' 1Q Results Meet Expectations
… quarter's significant rise in price. Meanwhile, Allergan 's AGN successful litigation to block Merz Pharma's launch ..... Xeomin as a bigger threat to Medicis' Dysport than to Allergan 's Botox. Once Merz launches in 2013, we expect …
-
Wall Street Breakfast: Must-Know News
Wall Street Breakfast Editors submit: Top Stories Carlos Slim makes first big foray into Europe. Carlos Slim's America Movil ( AMX ) intends to increase its stake in KPN ( KKPNY.PK ) to 28% from 4.8% by offering to buy shares for €8 each, which represents a premium of 23% to the Dutch telecom ...
-
Allergen receives subpoena over its anti-obesity device
May 8 (Reuters) - U.S. healthcare group Allergan has received a subpoena from the U.S. government over its gastric banding system that is used to treat obesity.
-
Allergan ( AGN ) has received a subpoena from the Department of Health's Inspector General over Lap-Band, a gastric band that helps people lose weight. The device generated $203.1M in sales last year.
Allergan ( AGN ) has received a subpoena from the Department of Health's Inspector General over Lap-Band, a gastric band that helps people lose weight. The device generated $203.1M in sales last year. Post your comment!
-
QLT's Pipeline Remains on Track While Competitive Pressures Mount
… effectiveness in its glaucoma trials with Xalatan, we think these punctal plugs face considerable competition, such as Allergan 's AGN injectable devices for glaucoma and retinal diseases in development. Also, management also announced a new potential …
-
Allergan Management Discusses Q1 2012 Results - Earnings Call Transcript
Allergan ( AGN ) Q1 2012 Earnings Call May 02, 2012 11:00 am ET Executives James M. Hindman - Chief Financial Officer David E.I. Pyott …